Former junior welterweight titlist Kendall Holt believes the issues surrounding his atypical urine test following an eighth-round knockout loss to Lamont Peterson in their Feb. 22 world title fight have been cleared up, but he still needs further medical testing.
Holt’s sample showed the presence of the banned substance human chorionic gonadotropin (HCG). However, the test results were deemed atypical -- simply not normal -- as opposed to a failed drug test because HCG can be naturally produced by the body and could be an indicator of some other medical issue, including the presence of cancer.
On Monday Holt released a statement updating the situation.
“I am pleased to announce that according to laboratory results I am not under suspicion of having taken a banned substance in connection with my bout against Lamont Peterson,” Holt said. “We have received an email from Dr. David Eichner, director of the [World Anti-Doping Agency] accredited Sports Medicine Research and Testing Laboratory that my results ‘do not suggest doping.’
“As explained to me, ‘intact HCG’ indicates the use of that banned substance. A confirmatory test reflected that I did not have ‘intact HCG’ and thus doping was ruled out in my case. There is an atypical finding for ‘non-intact HCG,’ which, as explained to me, is naturally produced. That finding will be explored further by my physicians. This explanation, too, was provided directly by the Sports Medicine Research and Testing Laboratory located in Salt Lake City.
“I requested a full WADA drug screening at the time of my bout with Lamont Peterson. Under the circumstances I am very glad that I did because it not only provided protection against drug cheating but also alerted me when I finally got the proper information of the need for further medical testing. I look forward to returning to the ring at 147 pounds.”